1
|
Pierau M, Kriegler S, Rickhoff C, Paulisch TO, Wegner T, Alavizargar A, Heuer A, Winter R, Glorius F. Neutral Imidazole Lipid Analogues Exhibit Improved Properties for Artificial Model Biomembranes. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2025; 41:10991-11002. [PMID: 40272991 DOI: 10.1021/acs.langmuir.5c00478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/26/2025]
Abstract
In recent years, a variety of lipid-mimetic imidazolium salts have been developed and applied to investigate biological membranes and related processes. Despite their overall similar properties to natural lipids, there are potential drawbacks including cytotoxicity attributed to the cationic charge. Herein, we report the investigation of a novel class of electronically neutral imidazole-based lipids. In comparison to their positively charged congeners, they show improved biophysical properties and higher similarity to native lipids. By employing calorimetry, fluorescence spectroscopies, and fluorescence and atomic force microscopy, we examined changes in the thermotropic phase behavior, lipid order parameter, fluidity, and lateral membrane organization upon incorporation of the lipid mimetics. Depending on the characteristic of the lipid chains, charge of the headgroup, and substitution pattern, we observed changes in lipid order and fluidity, thus allowing modulation and fine-tuning of the physicochemical properties of the modified membrane. Notably, a newly synthesized imidazole-based cholesterol showed membrane properties very similar to natural cholesterol. Extensive computational studies indicate effective mimicking of cholesterol and reveal its capability to participate in raft formation. This new class of neutral imidazole lipid analogues is expected to lead to better molecular probes and tools.
Collapse
Affiliation(s)
- Marco Pierau
- Institute of Organic Chemistry, University of Münster, Corrensstraße 36, D-48149 Münster, Germany
| | - Simon Kriegler
- Department of Chemistry and Chemical Biology, Physical Chemistry I - Biophysical Chemistry, TU Dortmund University, D-44221 Dortmund, Germany
| | - Clara Rickhoff
- Institute of Physical Chemistry, University of Münster, D-48149 Münster, Germany
| | - Tiffany O Paulisch
- Institute of Organic Chemistry, University of Münster, Corrensstraße 36, D-48149 Münster, Germany
| | - Tristan Wegner
- Institute of Organic Chemistry, University of Münster, Corrensstraße 36, D-48149 Münster, Germany
| | - Azadeh Alavizargar
- Institute of Physical Chemistry, University of Münster, D-48149 Münster, Germany
| | - Andreas Heuer
- Institute of Physical Chemistry, University of Münster, D-48149 Münster, Germany
| | - Roland Winter
- Department of Chemistry and Chemical Biology, Physical Chemistry I - Biophysical Chemistry, TU Dortmund University, D-44221 Dortmund, Germany
| | - Frank Glorius
- Institute of Organic Chemistry, University of Münster, Corrensstraße 36, D-48149 Münster, Germany
| |
Collapse
|
2
|
Chen PHB, Li XL, Baskin JM. Synthetic Lipid Biology. Chem Rev 2025; 125:2502-2560. [PMID: 39805091 PMCID: PMC11969270 DOI: 10.1021/acs.chemrev.4c00761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2025]
Abstract
Cells contain thousands of different lipids. Their rapid and redundant metabolism, dynamic movement, and many interactions with other biomolecules have justly earned lipids a reputation as a vexing class of molecules to understand. Further, as the cell's hydrophobic metabolites, lipids assemble into supramolecular structures─most commonly bilayers, or membranes─from which they carry out myriad biological functions. Motivated by this daunting complexity, researchers across disciplines are bringing order to the seeming chaos of biological lipids and membranes. Here, we formalize these efforts as "synthetic lipid biology". Inspired by the idea, central to synthetic biology, that our abilities to understand and build biological systems are intimately connected, we organize studies and approaches across numerous fields to create, manipulate, and analyze lipids and biomembranes. These include construction of lipids and membranes from scratch using chemical and chemoenzymatic synthesis, editing of pre-existing membranes using optogenetics and protein engineering, detection of lipid metabolism and transport using bioorthogonal chemistry, and probing of lipid-protein interactions and membrane biophysical properties. What emerges is a portrait of an incipient field where chemists, biologists, physicists, and engineers work together in proximity─like lipids themselves─to build a clearer description of the properties, behaviors, and functions of lipids and membranes.
Collapse
Affiliation(s)
- Po-Hsun Brian Chen
- Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York 14853, United States
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| | - Xiang-Ling Li
- Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York 14853, United States
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| | - Jeremy M Baskin
- Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York 14853, United States
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States
| |
Collapse
|
3
|
Schultz C, Wegner T, Heusel C, Gallagher T, Zheng Y, Werner M, Wegner SV, Meyer-Zedler T, Werz O, Schmitt M, Popp J, Glorius F. Alkyne-tagged imidazolium-based membrane cholesterol analogs for Raman imaging applications. Chem Sci 2024:d4sc03155e. [PMID: 39156930 PMCID: PMC11325193 DOI: 10.1039/d4sc03155e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2024] [Accepted: 07/24/2024] [Indexed: 08/20/2024] Open
Abstract
Cholesterol is an important lipid playing a crucial role in mediating essential cellular processes as well as maintaining the basic structural integrity of biological membranes. Given its vast biological importance, there is an unabated need for sophisticated strategies to investigate cholesterol-mediated biological processes. Raman-tagged sterol analogs offer the advantage of being visualizable without the need for a bulky dye that potentially affects natural membrane integration and cellular interactions as it is the case for many conventionally used fluorescent analogs. Herein, we report a series of alkyne-tagged imidazolium-based cholesterol analogs (CHIMs) with large Raman scattering cross-sections that readily integrate into HEK cells and primary monocyte-derived macrophages and allow (multiplexed) cellular Raman imaging. We envision Raman-tagged CHIM analogs to be a powerful platform for the investigation of cholesterol-mediated cellular processes complementary to other established methods, such as the use of fluorescent analogs.
Collapse
Affiliation(s)
- Constanze Schultz
- Leibniz Institute of Photonic Technology (Leibniz-IPHT), Member of Leibniz Health Technologies, Member of the Leibniz Center for Photonics in Infection Research (LPI) Albert-Einstein-Str. 9 07745 Jena Germany
| | - Tristan Wegner
- University of Münster, Institute of Organic Chemistry Corrensstraße 40 48149 Münster Germany
| | - Corinna Heusel
- University of Münster, Institute of Organic Chemistry Corrensstraße 40 48149 Münster Germany
| | - Tim Gallagher
- University of Münster, Institute of Organic Chemistry Corrensstraße 40 48149 Münster Germany
| | - Yanjun Zheng
- University of Münster, Institute of Physiological Chemistry and Pathobiochemistry Waldeyerstraße 15 48149 Münster Germany
| | - Markus Werner
- Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University Jena Philosophenweg 14 07743 Jena Germany
| | - Seraphine V Wegner
- University of Münster, Institute of Physiological Chemistry and Pathobiochemistry Waldeyerstraße 15 48149 Münster Germany
| | - Tobias Meyer-Zedler
- Leibniz Institute of Photonic Technology (Leibniz-IPHT), Member of Leibniz Health Technologies, Member of the Leibniz Center for Photonics in Infection Research (LPI) Albert-Einstein-Str. 9 07745 Jena Germany
- Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Member of the Leibniz Center for Photonics in Infection Research (LPI), Friedrich Schiller University Jena Helmholtzweg 4 07743 Jena Germany
| | - Oliver Werz
- Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University Jena Philosophenweg 14 07743 Jena Germany
| | - Michael Schmitt
- Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Member of the Leibniz Center for Photonics in Infection Research (LPI), Friedrich Schiller University Jena Helmholtzweg 4 07743 Jena Germany
| | - Juergen Popp
- Leibniz Institute of Photonic Technology (Leibniz-IPHT), Member of Leibniz Health Technologies, Member of the Leibniz Center for Photonics in Infection Research (LPI) Albert-Einstein-Str. 9 07745 Jena Germany
- Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Member of the Leibniz Center for Photonics in Infection Research (LPI), Friedrich Schiller University Jena Helmholtzweg 4 07743 Jena Germany
| | - Frank Glorius
- University of Münster, Institute of Organic Chemistry Corrensstraße 40 48149 Münster Germany
| |
Collapse
|
4
|
Huo T, Zhao X, Cheng Z, Wei J, Zhu M, Dou X, Jiao N. Late-stage modification of bioactive compounds: Improving druggability through efficient molecular editing. Acta Pharm Sin B 2024; 14:1030-1076. [PMID: 38487004 PMCID: PMC10935128 DOI: 10.1016/j.apsb.2023.11.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Revised: 10/14/2023] [Accepted: 11/13/2023] [Indexed: 03/17/2024] Open
Abstract
Synthetic chemistry plays an indispensable role in drug discovery, contributing to hit compounds identification, lead compounds optimization, candidate drugs preparation, and so on. As Nobel Prize laureate James Black emphasized, "the most fruitful basis for the discovery of a new drug is to start with an old drug"1. Late-stage modification or functionalization of drugs, natural products and bioactive compounds have garnered significant interest due to its ability to introduce diverse elements into bioactive compounds promptly. Such modifications alter the chemical space and physiochemical properties of these compounds, ultimately influencing their potency and druggability. To enrich a toolbox of chemical modification methods for drug discovery, this review focuses on the incorporation of halogen, oxygen, and nitrogen-the ubiquitous elements in pharmacophore components of the marketed drugs-through late-stage modification in recent two decades, and discusses the state and challenges faced in these fields. We also emphasize that increasing cooperation between chemists and pharmacists may be conducive to the rapid discovery of new activities of the functionalized molecules. Ultimately, we hope this review would serve as a valuable resource, facilitating the application of late-stage modification in the construction of novel molecules and inspiring innovative concepts for designing and building new drugs.
Collapse
Affiliation(s)
- Tongyu Huo
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
| | - Xinyi Zhao
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
| | - Zengrui Cheng
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
| | - Jialiang Wei
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
- Changping Laboratory, Beijing 102206, China
| | - Minghui Zhu
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
| | - Xiaodong Dou
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
| | - Ning Jiao
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
- Changping Laboratory, Beijing 102206, China
- Shanghai Key Laboratory of Green Chemistry and Chemical Processes, East China Normal University, Shanghai 200062, China
| |
Collapse
|